News

MASTDISCS^® ID Nitrocefin discs enables rapid detection of ß-lactamase enzymes. The presence of ß lactamase confers resistance to penicillin and cephalosporin’s, resulting in inactivation of these antibiotics.

Registration is now open for The British Society for Microbial Technology (BSMT) 38^th Annual Scientific Meeting, held at the Royal Air Force Museum, Hendon on 11^th May 2023.

MAST URI^® Plates are made to the current EUCAST breakpoints for urinary tract infections.

MAST Group is excited to announce a multi-region distribution agreement with Nanōmix Corporation, a leader in the development of mobile point-of-care (POC) diagnostics, to distribute the Nanōmix eLab^® system in the United Kingdom, Germany, France, Ireland and South Africa.

Will you 'go blue' for World Antimicrobial Awareness Week this week?

This is the topic Mast Group Product Specialist Emily George will be discussing at the ACB UKMedLab22 scientific meeting on Wednesday 9th November.

MAST^® SPUTAGEST liquefying agent permits easy and effective isolation of organisms from sputum samples.

Reliable and accurate susceptibility testing of mastitis pathogens to Kanamycin-Cefalexin 30-15µg combination is now easier for Veterinary practitioners.

Mast is pleased to announce the launch of Ceftobiprole 5µg to the MASTDISCS^® Antimicrobial Susceptibility Test range.